Open Access
Issue
BIO Web Conf.
Volume 240, 2026
The 2026 International Conference on Biomedicine, Neuroscience and Biostatistics (ICBNB 2026)
Article Number 01007
Number of page(s) 5
Section Biomedicine, Neuroscience and Biostatistics
DOI https://doi.org/10.1051/bioconf/202624001007
Published online 24 June 2026
  • H. Dimaras, et al. Retinoblastoma. Nature Reviews Disease Primers. 1:15021(2015). [Google Scholar]
  • I.D. Fabian, et al. The management of retinoblastoma. Oncogene. 37(12):1551–1560 (2018). [Google Scholar]
  • C.L. Shields, J.A. Shields. Basic understanding of current classification and management of retinoblastoma. Current Opinion in Ophthalmology. 17(3):228–234 (2006). [Google Scholar]
  • F.L. Munier, et al. Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. Progress in Retinal and Eye Research. 73:100764 (2019). [Google Scholar]
  • D.H. Abramson, et al. Advanced unilateral retinoblastoma: The impact of ophthalmic artery chemosurgery on enucleation rate and patient survival at MSKCC. PLoS One. 15(5):e0232866 (2020). [Google Scholar]
  • J.H. Francis, et al. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival. Ophthalmology Retina. 2(9):941–949 (2018). [Google Scholar]
  • L.A. Dalvin, C.L. Shields. Modern treatment of retinoblastoma: A 2020 review. Indian Journal of Ophthalmology. 68(11):2356–2365 (2020). [Google Scholar]
  • F.L. Munier, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: From prohibition to conditional indications. British Journal of Ophthalmology. 96(8):1078–1083 (2012). [Google Scholar]
  • C.L. Shields, et al. Intravitreal chemotherapy for active vitreous seeding from retinoblastoma: Outcomes after 192 consecutive injections. Journal of Pediatric Ophthalmology and Strabismus. 57(2):85–94 (2020). [Google Scholar]
  • J.H. Francis, et al. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA Ophthalmology. 136(8):887–893 (2018). [Google Scholar]
  • A.S. Tomar, et al. Global retinoblastoma presentation and outcomes by treatment modality: A systematic review and meta-analysis. JAMA Ophthalmology. 140(3):249–257 (2022). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.